How BioNTech built an entire digital ecosystem in less than one year
Pr écis: Watch Michael Boehler, VP, Global Commercial& General Manager BioNTech SE explain how they built their digital eco-system in less than on year.YouTube URL: https://www.youtube.com/watch?v=ke5LxRTphBoVideo Thumbnail Image: Channels: Access and EvidenceMedicalMultichannelPatients and MedicalClinicalColumnCommercial (Source: EyeForPharma)
Source: EyeForPharma - December 8, 2021 Category: Pharmaceuticals Authors: Izzy Gladstone Source Type: news
Pharma ’s new leaders in field engagement: MSLs
As the COVID-19 pandemic hit and healthcare professionals (HCPs) became elusive, Medical Science Liaisons (MSLs) got to work by deftly transitioning into virtual engagement. With this transition came an expansion in responsibilities that has resulted in MSLs occupying a central role in pharma ’s field engagement strategy. But, what now?Some industry insiders didn ’t expect virtual engagement trends to continue as the pandemic eased, says Mark-Rees Saunders, Director of ExternalEngagement, Astellas: “But virtual channels have proven themselves to be an excellent opportunity and they are here to stay. Going forward, ...
Source: EyeForPharma - November 30, 2021 Category: Pharmaceuticals Authors: Andrew Stone Source Type: news
Making medicines sustainable
Healthcare ’s sustainability record to date leaves much to be desired. The sector contributes 4.4% of total global emissions, healthcare costs continue to rise, and waste is rife. At the same time, two billion people lack access to even basic healthcare.
These are big problems but there is one way to act on them at scale that will be a win for patients, care providers, taxpayers and pharma. Medicines waste is the problem and cutting it is the aim of the Sustainable Medicines Partnership, a body which is about to launch a new four-year programme to find solutions that will work at scale.Its director is Nazneen Rahman,...
Source: EyeForPharma - November 30, 2021 Category: Pharmaceuticals Authors: Andrew Stone Source Type: news
Reaching Gen-Z
Despite creditable ongoing efforts by pharma to represent the broadest and most diverse population of patients in research and care, younger patients still often don ’t get represented and consulted as they might. Only by building a closer understanding of them will pharma be able to serve them better. And it can only do this by first finding and listening to them. There ’s an obvious, if still under explored avenue here. “If you think about where younger people are, they ' re on social media, ” says Seth Rotberg, who co-founded Our Odyssey, a nonprofit organization dedicated to connecting young adults impacted ...
Source: EyeForPharma - November 24, 2021 Category: Pharmaceuticals Authors: Risa Kerslake Source Type: news
Helping patients help themselves
It ’s easy to imagine a future in which we take care of certain aspects of our health independent of healthcare providers. Limitless access to information, wearables and their attendant digital tools are part of the solution, but so is broader over-the-counter (OTC) access to safe and effective medicines.There ’s an opportunity here for health care companies to put patients even more at the centre of care and to help them achieve better outcomes.Self care also has enormous scope to lower the pressures and negative impacts on health systems globally, particularly for non-chronic and non-serious health conditions but al...
Source: EyeForPharma - November 19, 2021 Category: Pharmaceuticals Authors: Andrew Stone Source Type: news
The evolution of the pharma incubator
Digital health ’s time has clearly come and many big pharma businesses are eagerly trying to harness its opportunities via the incubator model. The change has been seismic. Take the COVID-19 pandemic-driven explosion of the use of telemedicine apps such as Doximity, where downloads increased by 38 times in 2020, along with apps that helped patients stay healthy, mental health apps to manage depression, anxiety or suicidal thoughts, and blood pressure apps.Health-related mobile applications available to consumers on top app stores worldwide now surpass 350,000, with more than 90,000 digital health apps added in 2020 — ...
Source: EyeForPharma - November 2, 2021 Category: Pharmaceuticals Authors: Andrew Stone Source Type: news
Speeding pharma ’s slow sustainability journey
As world leaders gather in Glasgow for COP26 to discuss the next steps in the bid to tackle climate change, pharma ’s sustainability record is coming under greater scrutiny than ever.The public glare reveals much room for improvement but also, happily, many positive next steps industry leaders can take for the good of their own companies as well as of society at large, and of the planet.This is the message that Gary Cohen, President, Health Care Without Harm wants them to take away as the imperative to do more and with greater urgency becomes clearer.There are several pillars around which pharma can effect positive chang...
Source: EyeForPharma - November 2, 2021 Category: Pharmaceuticals Authors: Andrew Stone Source Type: news
Payers and the ABCs of digital literacy
With the growing adoption of new digital technologies to improve patient care, comes the need to demonstrate their benefits to all stakeholders, including payers.
Showing that patients and HCPs understand, can use and benefit from digital elements is an important but arguably under addressed aspect of securing reimbursement for them. By putting patients at the heart of everything the company does, they are more likely to feel engaged and inspired to embrace new technologies, give themselves an injection or use an app, even if they are not digitally savvy.“Patients that are informed and engaged are more adherent to their ...
Source: EyeForPharma - September 24, 2021 Category: Pharmaceuticals Authors: Katie Osborne Source Type: news
Nurturing peer-to-peer interactions in a virtual world
As medical events pivoted from conference centers to virtual meeting rooms, learning opportunities continued. Lectures and presentations translated across to the new digital world, but with one notable exception.
The ‘small talk’ that leads to big talk was lost. From snatched conversations in passing, through to group debates, peer-to-peer interactions are the number one thing that physicians and key opinion leaders (KOLs) say they miss about physical events. “Peer interaction is essential for information exchange and to better understand trends in management of disease states from around the country,” says...
Source: EyeForPharma - September 21, 2021 Category: Pharmaceuticals Authors: Lucy Fulford Source Type: news
Medical Affairs & Social Media: A Brave New World
Is your company behind the curve on using social media because no one has the skills or managers think they ’re fine without it? This is a big mistake given surging social media use by health care providers (HCP) since the pandemic began.Today, 81% of HCPs use social media as a trusted channel for scientific exchange. Medical Affairs teams who don ’t get on board with social media are missing an effective strategy for forging relationships, providing information, and engaging customers, says Gregory Imber, chief engagement officer for the Healthcare Consultancy Group. “We live at the intersection of science and the ...
Source: EyeForPharma - September 17, 2021 Category: Pharmaceuticals Authors: Andrew Stone Source Type: news
How well is pharma incubating innovation?
Digital health startups are on fire right now as the big global trends create a following wind for the sector. The pandemic has accelerated the adoption of digital health as consumers increasingly adopt wearable tech, as the clinical impact of digital health became apparent during 2020, and as everyone looks to a future of high demand and stretched healthcare systems and budgets. Digital health ’s scope to manage healthcare costs, to help keep people well and to support physicians in their work flows has become abundantly clear to investors, says Dominick Kennerson, Global Head G4A Digital Health at Bayer, one of the...
Source: EyeForPharma - July 7, 2021 Category: Pharmaceuticals Authors: Andrew Stone Source Type: news
Unlocking the full potential of biosimilars
Ageing populations, the rise of chronic diseases, and healthcare systems stretched to breaking point by COVID-19, all raise questions over the long-term sustainability of healthcare. Biosimilars, follow on medicine of an existing biologic when the patent has expired, are effective but often underused options to help treat many diseases while reducing spending on medicines and freeing up resources to invest in other areas.With healthcare systems working hard to get back on track, will 2021 be the year that biosimilars are able to deliver more fully on their promise of more affordable, accessible and sustainable treatments...
Source: EyeForPharma - July 2, 2021 Category: Pharmaceuticals Authors: Pamela Whitby Source Type: news
Up close and personal – The Dr. Kevin Williams story
From a young age, Dr. Kevin Williams looked to his father as a role model. Back in 1952, his father became the third African American physician in Baton Rouge, Louisiana, despite barriers and discrimination faced by Black professionals in the medical field. “It was a different time,” says Kevin. “When my father first opened his practice, none of the hospitals would give him admitting privileges.” At his office, Kevin ’s father saw patients on a first come, first served basis. Patients in the area were so eager to see him that they started lining up at 4 o’clock each morning, even creating their own sign-...
Source: EyeForPharma - June 7, 2021 Category: Pharmaceuticals Authors: Jill Donahue Source Type: news
Up close and personal – The Dr. Kevin Williams story
From a young age, Dr. Kevin Williams looked to his father as a role model. Back in 1952, his father became the third African American physician in Baton Rouge, Louisiana, despite barriers and discrimination faced by Black professionals in the medical field. “It was a different time,” says Kevin. “When my father first opened his practice, none of the hospitals would give him admitting privileges.” At his office, Kevin ’s father saw patients on a first come, first served basis. Patients in the area were so eager to see him that they started lining up at 4 o’clock each morning, even creating their own sign-...
Source: EyeForPharma - June 7, 2021 Category: Pharmaceuticals Authors: Jill Donahue Source Type: news
On the journey from pill to platform
As pharma ’s business model increasingly moves beyond the pill towards the patient and the entire therapeutic context, Medical Affairs was already being earmarked as an increasingly pivotal function.
The pandemic-driven changes that have roiled the healthcare sector have been an accelerant to this disruptive trend.
Last year Medical Affairs became an even more essential partner. Healthcare providers (HCPs) have been consulting Medical Science Liaisons (MSLs) for advice and trusted content in greater numbers, increasingly so in a digital context.
There are huge opportunities here for Medical Affairs to provide va...
Source: EyeForPharma - June 3, 2021 Category: Pharmaceuticals Authors: Andrew Stone Source Type: news